Capital Analysts LLC’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $17K | Sell |
256
-148
| -37% | -$9.83K | ﹤0.01% | 1055 |
|
2025
Q1 | $28K | Sell |
404
-100
| -20% | -$6.93K | ﹤0.01% | 917 |
|
2024
Q4 | $43K | Buy |
504
+53
| +12% | +$4.52K | ﹤0.01% | 782 |
|
2024
Q3 | $54K | Buy |
451
+332
| +279% | +$39.8K | ﹤0.01% | 709 |
|
2024
Q2 | $17K | Sell |
119
-60
| -34% | -$8.57K | ﹤0.01% | 883 |
|
2024
Q1 | $23K | Buy |
179
+140
| +359% | +$18K | ﹤0.01% | 797 |
|
2023
Q4 | $4K | Sell |
39
-29
| -43% | -$2.97K | ﹤0.01% | 979 |
|
2023
Q3 | $6K | Buy |
+68
| New | +$6K | ﹤0.01% | 960 |
|
2023
Q2 | – | Sell |
-50
| Closed | -$4K | – | 1023 |
|
2023
Q1 | $4K | Buy |
+50
| New | +$4K | ﹤0.01% | 886 |
|
2021
Q3 | – | Sell |
-70
| Closed | -$3K | – | 1016 |
|
2021
Q2 | $3K | Sell |
70
-1,750
| -96% | -$75K | ﹤0.01% | 854 |
|
2021
Q1 | $61K | Buy |
1,820
+1,750
| +2,500% | +$58.7K | ﹤0.01% | 555 |
|
2020
Q4 | $2K | Buy |
+70
| New | +$2K | ﹤0.01% | 697 |
|
2016
Q4 | – | Sell |
-7,240
| Closed | -$151K | – | 379 |
|
2016
Q3 | $151K | Buy |
+7,240
| New | +$151K | 0.03% | 185 |
|